Journal of Clinical Oncology, Vol 21, Issue 3
(February), 2003: 520-529
© 2003 American Society for Clinical Oncology
Prospective Evaluation of a Follow-Up Schedule in Cutaneous Melanoma Patients: Recommendations for an Effective Follow-Up Strategy
Claus Garbe,
Andrena Paul,
Hanna Kohler-Späth,
Ulf Ellwanger,
Waltraud Stroebel,
Monika Schwarz,
Bettina Schlagenhauff,
Friedegund Meier,
Birgit Schittek,
Hans-Juergen Blaheta,
Andreas Blum,
Gernot Rassner
From the Department of Dermatology, Skin Cancer Program, Eberhard-Karls-University of Tuebingen; and Central Malignant Melanoma Registry of the German Society of Dermatology, Tuebingen, Germany.
Address reprint requests to Claus Garbe, MD, Professor of Dermatology, Department of Dermatology, Eberhard-Karls-University, Liebermeisterstrasse 25, 72076 Tuebingen, Germany; email: claus.garbe{at}med.uni-tuebingen.de.
Purpose: To prospectively examine and evaluate the results of follow-up procedures in a large cohort of cutaneous melanoma patients.
Patients and Methods: This was a prospective study in 2,008 consecutive patients with stage I to IV cutaneous melanoma from 1996 to 1998 on the yield of stage-appropriate follow-up examinations according to the German guidelines. Documentation of patient and follow-up data comprised patient demography, primary tumor specifics, and any clinical and technical examinations performed. The detection of metastasis was classified as early or late, and the means of their detection and the resulting overall survival probabilities were examined.
Results: A total of 3,800 clinical examinations and 12,398 imaging techniques were documented. Sixty-two second primary melanomas in 46 patients and 233 disease recurrences in 112 patients were detected during this time. In stage I to III disease, physical examination was responsible for the discovery of 50% of all recurrences. In the primary tumor stages, 21% of all recurrences were discovered by lymph node sonography, with the majority being classified as early detection. Forty-eight percent of the recurrences were classified as early detection, and these patients had a significant benefit of overall survival probability.
Conclusion: The results of our study suggest that an elaborated follow-up schedule in cutaneous melanoma is suitable for the early detection of second primary melanomas and early recurrences. The intensity of clinical and technical examinations can be reduced during follow-up of patients in the primary tumor stages and may be intensified in locoregional disease. Recommendations for an effective follow-up strategy are outlined.
Supported by grant no. M3/95/Ga I from the Deutsche Krebshilfe, Bonn, Germany.
This article has been cited by other articles:
|
|
|
|
 
K. M. Dalal, Q. Zhou, K. S. Panageas, M. S. Brady, D. P. Jaques, and D. G. Coit
Methods of Detection of First Recurrence in Patients with Stage I/II Primary Cutaneous Melanoma After Sentinel Lymph Node Biopsy
Ann. Surg. Oncol.,
August 1, 2008;
15(8):
2206 - 2214.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Grange, F. Vitry, F. Granel-Brocard, D. Lipsker, F. Aubin, G. Hedelin, S. Dalac, F. Truchetet, C. Michel, M.-L. Batard, et al.
Variations in Management of Stage I to Stage III Cutaneous Melanoma: A Population-Based Study of Clinical Practices in France
Arch Dermatol,
May 1, 2008;
144(5):
629 - 636.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. B. Francken, H. M. Shaw, N. A. Accortt, S.-J. Soong, H. J. Hoekstra, and J. F. Thompson
Detection of First Relapse in Cutaneous Melanoma Patients: Implications for the Formulation of Evidence-Based Follow-up Guidelines
Ann. Surg. Oncol.,
June 1, 2007;
14(6):
1924 - 1933.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Z. Belhocine, A. M. Scott, E. Even-Sapir, J.-L. Urbain, and R. Essner
Role of Nuclear Medicine in the Management of Cutaneous Malignant Melanoma
J. Nucl. Med.,
June 1, 2006;
47(6):
957 - 967.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Reinhardt, A. Y. Joe, U. Jaeger, A. Huber, A. Matthies, J. Bucerius, R. Roedel, H. Strunk, T. Bieber, H.-J. Biersack, et al.
Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive Patients
J. Clin. Oncol.,
March 1, 2006;
24(7):
1178 - 1187.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Saiag, M. Bernard, A. Beauchet, M.-L. Bafounta, I. Bourgault-Villada, and S. Chagnon
Ultrasonography Using Simple Diagnostic Criteria vs Palpation for the Detection of Regional Lymph Node Metastases of Melanoma
Arch Dermatol,
February 1, 2005;
141(2):
183 - 189.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-H. Schmid-Wendtner and W. Burgdorf
Ultrasound Scanning in Dermatology
Arch Dermatol,
February 1, 2005;
141(2):
217 - 224.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. M. Eggermont
Reducing the Need for Sentinel Node Procedures by Ultrasound Examination of Regional Lymph Nodes
Ann. Surg. Oncol.,
January 1, 2005;
12(1):
3 - 5.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. C. Starritt, R. F. Uren, R. A. Scolyer, M. J. Quinn, and J. F. Thompson
Ultrasound Examination of Sentinel Nodes in the Initial Assessment of Patients With Primary Cutaneous Melanoma
Ann. Surg. Oncol.,
January 1, 2005;
12(1):
18 - 23.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Leiter, P. G. Buettner, T. K. Eigentler, and C. Garbe
Prognostic Factors of Thin Cutaneous Melanoma: An Analysis of the Central Malignant Melanoma Registry of the German Dermatological Society
J. Clin. Oncol.,
September 15, 2004;
22(18):
3660 - 3667.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Tsao, M. Feldman, J. E. Fullerton, A. J. Sober, D. Rosenthal, and W. Goggins
Early Detection of Asymptomatic Pulmonary Melanoma Metastases by Routine Chest Radiographs Is Not Associated With Improved Survival
Arch Dermatol,
January 1, 2004;
140(1):
67 - 70.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. M. Johnson, C. R. Bradford, S. B. Gruber, V. K. Sondak, and J. L. Schwartz
Staging Workup, Sentinel Node Biopsy, and Follow-up Tests for Melanoma: Update of Current Concepts
Arch Dermatol,
January 1, 2004;
140(1):
107 - 113.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Saiag
Recommendations for an Effective Follow-Up Strategy in Melanoma Patients Should Be Tailored to the Investigations Performed During Initial Staging
J. Clin. Oncol.,
October 1, 2003;
21(19):
3706 - 3706.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Autier, J. W. Coebergh, M. Boniol, J.-F. Dore, E. de Vries, and A. M.M. Eggermont
Management of Melanoma Patients: Benefit of Intense Follow-Up Schedule Is Not Demonstrated
J. Clin. Oncol.,
October 1, 2003;
21(19):
3707 - 3707.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Garbe and U. Leiter
In Reply:
J. Clin. Oncol.,
October 1, 2003;
21(19):
3706 - 3707.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Garbe and U. Leiter
In Reply:
J. Clin. Oncol.,
October 1, 2003;
21(19):
3707 - 3708.
[Full Text]
[PDF]
|
|
|
|
